Using MRI scans to display screen for prostate most cancers might "significantly" cut back the variety of males dying from the illness, researchers have stated.

The "sobering" outcomes reinforce "the need to consider a new approach to prostate cancer screening", the examine's chief investigator stated.

Prostate cancer is the commonest most cancers present in males. Those over 50 who're experiencing signs together with needing to make use of the bathroom extra incessantly and blood within the urine can request a blood check.

The assessments, which search for excessive ranges of a protein referred to as PSA, have been linked to over-diagnosis and over-treatment of low-risk most cancers.

More than 300 males underwent a PSA check in addition to an MRI scan within the examine led by University College London, University College London Hospitals NHS (UCLH) Foundation Trust and King's College London.

Of those that had a mean PSA rating, 16% had an MRI scan that indicated the presence of prostate most cancers. More than 30 of those males wouldn't have been referred for additional investigation.

"Our results give an early indication that MRI could offer a more reliable method of detecting potentially serious cancers early, with the added benefit that less than 1% of participants were 'over-diagnosed' with low-risk disease," Professor Caroline Moore, the examine's chief investigator and a guide surgeon at UCLH, stated.

Simon Grieveson, assistant director of analysis at Prostate Cancer UK, stated: "MRI scans have revolutionised the way we diagnose prostate cancer and it's great to see research into how we might use these scans even more effectively."

Read extra:Cancer check labels to put inside underwearStem cell DNA match search for three-month-old baby diagnosed with rare blood cancerThousands give up waiting for NHS 24 helpline response

Professor Mark Emberton, guide urologist at UCLH, stated: "Given how treatable prostate cancer is when caught early, I'm confident that a national screening programme will reduce the UK's prostate cancer mortality rate significantly."

The examine was printed within the medical journal BMJ Oncology.

Another trial, often called Limit, is being carried out with a a lot bigger variety of sufferers, which the analysis group stated is the "next step towards a national prostate screening programme".

The trial may also try to recruit extra black males, Mr Grieveson stated.